These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7516329

  • 1. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K, Léránt I, Tenekejiev K, Machovich R.
    J Biol Chem; 1994 Jun 24; 269(25):17030-4. PubMed ID: 7516329
    [Abstract] [Full Text] [Related]

  • 2. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K, Komorowicz E, Machovich R.
    Blood Coagul Fibrinolysis; 1994 Dec 24; 5(6):905-11. PubMed ID: 7534486
    [Abstract] [Full Text] [Related]

  • 3. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.
    Kolev K, Komorowicz E, Owen WG, Machovich R.
    Thromb Haemost; 1996 Jan 24; 75(1):140-6. PubMed ID: 8713793
    [Abstract] [Full Text] [Related]

  • 4. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK, Gonias SL.
    Biochem J; 1991 Apr 01; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [Abstract] [Full Text] [Related]

  • 5. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK, Wolf B, Gonias SL.
    Thromb Res; 1990 Aug 01; 59(3):449-62. PubMed ID: 1700488
    [Abstract] [Full Text] [Related]

  • 6. Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.
    Gonias SL, Figler NL.
    Biochem J; 1988 Oct 15; 255(2):725-30. PubMed ID: 2462416
    [Abstract] [Full Text] [Related]

  • 7. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK, Vasudevan J, Gonias SL.
    Arterioscler Thromb; 1992 Jun 15; 12(6):708-16. PubMed ID: 1375508
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM, Pizzo SV.
    Biochem J; 1992 Aug 15; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of the inhibition of free and elastin-bound human pancreatic elastase by alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
    Laurent P, Bieth JG.
    Biochim Biophys Acta; 1989 Feb 23; 994(3):285-8. PubMed ID: 2465784
    [Abstract] [Full Text] [Related]

  • 10. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E, Thorsen S.
    Biochem J; 1981 Sep 01; 197(3):619-28. PubMed ID: 6459779
    [Abstract] [Full Text] [Related]

  • 11. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.
    Brower MS, Harpel PC.
    Blood; 1983 May 01; 61(5):842-9. PubMed ID: 6219725
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
    Petersen LC, Clemmensen I.
    Biochem J; 1981 Oct 01; 199(1):121-7. PubMed ID: 6175313
    [Abstract] [Full Text] [Related]

  • 13. Flow rate-modulated dissolution of fibrin with clot-embedded and circulating proteases.
    Komorowicz E, Kolev K, Léránt I, Machovich R.
    Circ Res; 1998 Jun 01; 82(10):1102-8. PubMed ID: 9622163
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
    Komorowicz E, Kolev K, Machovich R.
    Biochemistry; 1998 Jun 23; 37(25):9112-8. PubMed ID: 9636057
    [Abstract] [Full Text] [Related]

  • 15. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation.
    Kolev K, Tenekedjiev K, Komorowicz E, Machovich R.
    J Biol Chem; 1997 May 23; 272(21):13666-75. PubMed ID: 9153217
    [Abstract] [Full Text] [Related]

  • 16. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
    Gonias SL, Figler NL, Braud LL.
    Blood; 1988 Nov 23; 72(5):1658-64. PubMed ID: 2460159
    [Abstract] [Full Text] [Related]

  • 17. Interaction between human pancreatic elastase and plasma protease inhibitors.
    Gustavsson EL, Ohlsson K, Olsson AS.
    Hoppe Seylers Z Physiol Chem; 1980 Nov 23; 361(2):169-76. PubMed ID: 6153632
    [Abstract] [Full Text] [Related]

  • 18. Determination of functional activity of alpha 1-protease inhibitor and alpha 2-macroglobulin in human plasma using elastase.
    Gaillard MC, Kilroe-Smith TA.
    J Clin Chem Clin Biochem; 1987 Mar 23; 25(3):167-72. PubMed ID: 2439646
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW.
    Thromb Haemost; 1993 Feb 01; 69(2):141-6. PubMed ID: 7681223
    [Abstract] [Full Text] [Related]

  • 20. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M, Brufatto N, Neill E, Nesheim M.
    J Biol Chem; 2004 Apr 02; 279(14):13340-5. PubMed ID: 14715654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.